Buscar
Mostrando ítems 1-5 de 5
Artículo
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
(Lippincott Williams & Wilkins, 2017)
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment options such as CT-P13 promises to improve the ...
Artículo
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients
(Aran Ediciones S.A., 2017)
Objective: To evaluate the efficacy and safety of a quadruple regimen (BMTO) of the “3-in-1 capsule” (containing bismuth subcitrate potassium, metronidazole and tetracycline) plus omeprazole in naïve and previously ...
Artículo
A survey-based analysis on endoscopic quality indicators compliance among Spanish endoscopists
(Aran Ediciones S.A., 2017)
Introduction: Endoscopy plays a key role for the diagnosis and management of gastrointestinal disorders. Therefore, quality indicators have been widely proposed in order to optimize endo scopic practice. The aims of ...
Artículo
Evolution of the incidence of inflammatory bowel disease in Southern Spain
(Aran Ediciones S.A., 2017)
Background: The incidence of inflammatory bowel disease is increasing in Europe and in Spain. However, there is no recent data from Southern Spain. Objectives: To determine the evolution of the hospital incidence ...
Artículo
Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey
(Aran Ediciones S.A., 2017)
colitis (UC) about their disease and access to a specialist are important to improve health outcomes. Our objective was to determine, by collecting information directly from the patients, their information sources ...